ElevateBio-CIRM unite to advance regenerative medicine development

Date: 2022-08-24   Author: Pankaj Singh  Category: #news

ElevateBio-CIRM unite to advance regenerative medicine development

ElevateBio, LLC has reportedly announced a partnership with the CIRM (California Institute for Regenerative Medicine) to promote the discovery and development of regenerative medications.

The collaboration will enable ElevateBio to give biopharmaceutical firms and academic institutions that have been awarded CIRM Discovery and Translational Grants access to well-characterized and high-quality iPSC lines. ElevateBio will also facilitate easier access to its viral vector technology, analytical development, process development, and GMP (Good Manufacturing Practice) production capabilities, which are part of its integrated ecosystem designed to power the gene and cell therapy industry.

Chairman and Chief Executive Officer of ElevateBio, David Hallal, has stated that this alliance reflects the novelty of the company’s iPSC platform and recognizes its next-gen cell lines aimed at solving industry issues and facilitating time and cost savings for its partners involved in the development of iPSC-derived medicines.

According to Hallal, this partnership will set a new standard for iPSCs to streamline the process from research to development and commercialization. By leveraging ElevateBio’s unique enabling technology ecosystem and expertise, strategic partners will have the means to extract maximum benefits from regenerative medicines, he added.

CIRM, with the support of funding worth USD 5.5 billion from the state of California, has funded over 81 clinical trials. Currently, it is offering support to nearly 161 active research projects for regenerative medicine, from candidate discovery to phase III trials.

The collaboration, as part of the CIRM Industry Alliance program, will give CIRM Awardees the option of licensing iPSC lines from ElevateBio, which are produced in feeder-free, xeno-free conditions through non-integrating technologies. These lines are also able to gain access to other enabling technologies, such as cell and vector engineering, gene editing, and end-to-end services critical for regenerative medicine development in the integrated ecosystem of ElevateBio.

For the uninitiated, ElevateBio is a technology-powered firm focused on powering the development of transformative gene and cell therapeutics. With a strong team of drug developers, company builders, and scientists, the company is aiming to blur the line between healthcare and technology.

Source Credit: https://www.businesswire.com/news/home/20220823005087/en/ElevateBio-Partners-with-the-California-Institute-for-Regenerative-Medicine-to-Accelerate-the-Development-of-Regenerative-Medicines

About Author

Pankaj Singh linkdin-boxtwitter

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

Post Recommendents

Cardiac Resynchronization Therapy (CRT) Devices Market to 2026 - Growth Trends and Revenue Statistics

Author: Rahul Varpe

A highly analytical qualitative as well as quantitative evaluation of the Cardiac Resynchronization Therapy (CRT) Devices Market has been covered in this report. The study evaluates the myriad aspects of this industry by taking into consideration ...

Medical Products Market Growth Rate, Revenue and Demand Analysis to 2026

Author: Rahul Varpe

An extremely definite evaluation of the Medical Products Market in terms of qualitative as well as quantitative analysis has been covered in this report. The myriad aspects of this industry, having considered its historical and forecast data have ...

Intensive Care Beds Market - Geography Insights and Opportunity Analysis to 2026

Author: Rahul Varpe

The latest study provides an in-depth analysis of the Intensive Care Beds Market focusing on various market definitions, segmentations, sub-segmentations, products, as well as applications. The report further details of the competitive landscape &...